Analyst Conferences In Brief
This article was originally published in The Gray Sheet
Executive Summary
Stryker: Corin's Cormet hip resurfacing device will be sold by Stryker in the U.S. under a deal struck with the British orthopedic firm, Stryker CFO Dean Bergy said Sept. 8 at the Thomas Weisel Healthcare Tailwinds Conference in Boston. "It's very clear that hip resurfacing has been very well received in many European markets, Australia and Canada. I don't know that the opportunity will be as great in the U.S., but we felt like we'd have to be on the forefront of this technology," Bergy said. Stryker will purchase the hips from Corin on a transfer price basis. Corin has already submitted a PMA application to FDA for the device. If approved, the device will likely compete against Smith & Nephew's Birmingham Hip Resurfacing device, which garnered a positive recommendation from FDA's Orthopaedic & Rehabilitation Devices Panel Sept. 8 in Gaithersburg, Md....
You may also be interested in...
FDA Ortho Panel Will See Second Hip Resurfacing System In Cormet
Corin Group's Cormet will be the second hip resurfacing product to go before an FDA advisory committee when the Orthopaedic and Rehabilitation panel considers the device's PMA next month
FDA Ortho Panel Will See Second Hip Resurfacing System In Cormet
Corin Group's Cormet will be the second hip resurfacing product to go before an FDA advisory committee when the Orthopaedic and Rehabilitation panel considers the device's PMA next month
Women Courted At Orthopedics Meeting; Zimmer Touts “Gender Solutions”
The major orthopedic companies are energetically marketing to women to reverse last year's sluggish knee implant sales growth